An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie ...
An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie, ...
The market misinterprets past COVID-era revenue growth for 10x Genomics and fails to integrate current sector growth. Read ...
Tempus AI's dual-engine model drives $1.27B revenues, with Diagnostics dominating and Data monetization accelerating growth ...
Researchers built an open tool to handle complex genome sequencing data, offering automated quality control, improved variant ...
Morning Overview on MSN
AI-guided CRISPR tool aims to make DNA edits more precise and safer
Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...
OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.
An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie, using artificial ...
Starlust on MSN
ESA’s Hera probe to catch up with Didymos, home to the only asteroid ever deflected by humans
Didymos forms part of a binary system with the smaller asteroid Dimorphos.
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...
Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results